OKYO Pharma Ltd. Form 6-K Summary
Business Context and Reporting Period
OKYO Pharma Ltd., a foreign private issuer filing annual reports on Form 20-F, filed this Form 6-K on November 29, 2023. The filing reports an October 31, 2023 announcement regarding the company’s annual general meeting, scheduled for December 14, 2023 at 2:30 p.m. London time (9:30 a.m. U.S. Eastern time).
Financial Metrics
This filing is administrative in nature and does not provide revenue, profit, cash flow, margin, debt, liquidity, operating, or other financial metrics.
Material Changes Versus Prior Period
The filing does not report financial or operational changes versus a comparable prior period.
Guidance, Outlook, Risks, and Unusual Items
No earnings guidance, business outlook, risk updates, contingencies, or unusual financial items are disclosed. The attached annual general meeting notice is furnished as Exhibit 99.1 and is not deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934.
Key Facts for Investors to Verify
- Confirm the annual general meeting date, time, location or access details, and agenda in Exhibit 99.1.
- Review any proposed resolutions, record-date information, voting procedures, and proxy materials associated with the meeting.
- Consult the company’s latest financial statements and other SEC filings for financial performance, liquidity, capital requirements, and clinical or operating updates, which are not provided here.